Serology

Leptospirosis serology

Clinical material provided (Liquid Serum – 0.5 mL) to assess the detection of Leptospirosis using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Leptospirosis IgG; IgM; Total Antibody; Leptospirosis Agglutination

Product details last updated on August 9, 2019

Lyme Disease serology

Clinical material provided (Liquid Serum / Plasma – 0.5 mL) to assess the detection of Lyme Disease using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Lyme Disease IgG Confirmatory; IgM Confirmatory; IgG; IgM; Total Antibody

Product details last updated on July 29, 2019

Measles serology

Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Measles using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Measles IgG; IgM; Total Antibody

Product details last updated on July 29, 2019

Mumps serology

Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Mumps using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Mumps IgG; IgM; Total Antibody

Product details last updated on July 29, 2019

Mycoplasma serology

Clinical material provided (Liquid Serum / Plasma – 0.5 mL) to assess the detection of Mycoplasma pneumoniae using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Mycoplasma IgA; IgG; IgM; Total Antibody

Product details last updated on July 29, 2019

Parvovirus serology

Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Parvovirus using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Parvovirus IgG, Parvovirus IgM

Product details last updated on August 9, 2019

Point of Care – Human immunodeficiency virus (HIV)

Clinical material provided (Stabilised Whole blood/ Inactivated viral culture lysate – 0.4 mL) to assess the detection of HIV using Point of Care Assays

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

HIV Antigen PoCT; HIV Antibody PoCT

Product details last updated on July 29, 2019

Point of Care – Influenza A & B Antigen

Simulated clinical material provided (Inactivated viral culture lysate – 0.5 mL) to assess the detection of Influenza antigen using Point of Care Assays

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

Influenza A Antigen PoCT; Influenza B Antigen PoCT

Product details last updated on July 29, 2019

Point of Care – RSV Antigen

Simulated clinical material provided (Inactivated viral culture lysate – 0.5 mL) to assess the detection of RSV antigen using Point of Care Assays

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

RSV Antigen PoCT

Product details last updated on July 29, 2019

Q fever serology

Clinical material provided (Liquid Serum / Plasma – 0.4 mL) to assess the detection of Q Fever using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Q fever Phase 1 IgA; IgG; IgM; Total Antibody

Q fever Phase 2 IgA; IgG; IgM; Total Antibody

Product details last updated on July 29, 2019

QuantiFERON – TB serology

Material provided (Lyophilised Serum / Plasma) to assess the detection of QuantiFERON® – TB

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

QuantiFERON®  – TB (detection only)

Product details last updated on August 9, 2019

Rickettsia serology

Clinical material provided (Liquid Serum / Plasma – 0.4 mL) to assess the detection of various Rickettsial species using serological markers

Frequency / Number of samples

2 surveys / 2 samples per survey

Tests

Spotted Fever Group IgG; IgM; Total Antibody

Typhus Group Typhus Group IgG; Typhus Group IgM ;Total Antibody

Scrub Typhus Group IgG; IgM; Total Antibody

Product details last updated on August 9, 2019